Affimed Announces Filing for the Opening of Insolvency Proceedings
MANNHEIM, Germany, May 13, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients...
Staff
VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”) announced today that...
Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Announced accepted oral presentation of positive phase 3 randomized placebo controlled clinical trial results of CAN-2409 (aglatimagene besadenovec) in localized...
SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury
Indication Has Been Granted FDA Breakthrough Device Designation for Potential PMA FilingDENVER, May 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical...
Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor
Long-term clinical evaluation represents key advancement following successful first-in-human studyRUTHERFORD, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq:...
EnteroBiotix Presents Positive Data in Liver Cirrhosis at EASL 2025
EnteroBiotix Presents Positive Data in Liver Cirrhosis at EASL 2025 EBX-102 was well tolerated and showed multiple positive trends over placeboFindings support progression...
Reflect Scientific Secures Patents for Data Center Cooling with Cryogenic Innovation
OREM, Utah, May 13, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leader in cryogenic technology, today announced...
ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq:...
Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™
The AYON Body Contouring System is the first FDA cleared all-in-one platform for the aesthetic surgical suite Plan to initiate...
CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
- Updated BOND-003 clinical results presented at AUA showing best-in-disease durability and tolerability data for Cohort C with 24-month complete...
Remedy Plan Therapeutics Raises $18 Million Financing to Accelerate Advancement of Lead Asset RPT1G into Phase 1/2 Trials
Financing includes participation from Schooner Capital, Alexandria Venture Investments, and other existing investorsInvestment accelerates advancement of RPT1G, a novel NAMPT...
Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit
WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical...
KNoW Biological Receives FDA Breakthrough Device Designation
Atlanta-based firm to begin clinical trial on advanced warning seizure monitor ATLANTA, May 13, 2025 /PRNewswire/ -- KNoW Biological has...
Wincomm Wins Best Choice Award at COMPUTEX 2025 for AI-Driven Surgical Panel PC
HSINCHU, May 13, 2025 /PRNewswire/ -- Wincomm, a global leader in medical-grade computing solutions, has been awarded the Best Choice...
Fangzhou CEO Honored at 2025 VBEF Conference as Company Showcases AI Medical Innovations
SUZHOU, China, May 13, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, participated...
For Labbit, Semaphore Solutions Recognized in the Gartner® Market Guide for Laboratory Information Management Systems
VICTORIA, BC, May 13, 2025 /PRNewswire/ - Semaphore Solutions, a leading provider of laboratory informatics platforms, announced today that for...
GI Innovation and GI Biome Advance to the Semi-finals of XPRIZE Healthspan with Anti-Aging Potential of GI-102 and GIB-7 Combination Therapy
GI Innovation and GI Biome have been selected as a Top 40 semi-finalist in the XPRIZE Healthspan competition among 600 registered teams from 58...
Tyra Biosciences to Participate at Upcoming Investor Conferences
CARLSBAD, Calif., May 12, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation...
GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL’s Galleri® Multi-Cancer Early Detection (MCED) Test
MENLO PARK, Calif., May 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect...
Olio Raises $11M Series B Funding to Expand Product Innovation and Market Reach
Investment led by Fulcrum Equity Partners to accelerate Olio's mission of transforming care coordination. INDIANAPOLIS, May 12, 2025 /PRNewswire/ -- Olio,...